July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection by the U.S. Food and Drug Administration (FDA), with zero Form 483 observations. The FDA inspection reviewed QT Imaging’s Quality Management System (QMS) and related processes that support the company’s operations, with no Form 483 observations issued. The inspector also provided positive feedback regarding the organization of QT Imaging’s QMS and the company’s responsiveness throughout the inspection process.